A randomized control trial of primary care-based management of type 2 diabetes by a pharmacist in Pakistan

Table 3 Gender wise comparison of process outcome measures at final follow up; control vs intervention

Parameters	Control Arm [Mean ± SD]		Intervention Arm [Mean ± SD]		Comparison of Male Participants	Comparison of Female Participants
	Final follow up, n = 52		Final follow up, n = 83		Comparison of Male Participants	Comparison of Female Participants
	M = 17	F = 35	M = 26	F = 57	C_F vs I_F (p-values)	C_F vs I_F (p-values)
HbA1c (%)	9.7 ± 1.4	9.7 ± 1.3	7.9 ± 0.7	7.6 ± 0.9	0.0001**	0.0001**
eABG [mg/dL]	233.2 ± 39.9	231.4 ± 37.7	179.2 ± 21.6	171.4 ± 27.1	0.0001**	0.0001**
SBP [mm/Hg]	137.1 ± 6.4	136.7 ± 7.6	125.8 ± 8.3	123.1 ± 10.5	0.0001**	0.0001**
DBP [mm/Hg]	88.8 ± 3.8	88.7 ± 4.4	85.9 ± 4.7	87.1 ± 5.7	0.077	0.148
Cholesterol [mg/dL]	229.1 ± 78	217 ± 36.5	152.6 ± 27	153.8 ± 25.6	0.0001**	0.0001**
TG [mg/dL]	170.2 ± 47.3	173.4 ± 50	141.2 ± 24.1	143.1 ± 34.7	0.283	0.0001**
HDL-C [mg/dL]	48.3 ± 12.3	49.9 ± 14.8	47.8 ± 7.7	49.4 ± 8	0.210	0.170
LDL-C [mg/dL]	75.6 ± 93.5	85.8 ± 67.3	76.5 ± 25.2	75.7 ± 20.2	0.0001**	0.0001**
VLDL-C [mg/dL]	17 ± 18.5	22.3 ± 18.4	28.3 ± 4.8	28.6 ± 6.9	0.284	0.0002**
SCr [mg/dL]	0.9 ± 0.1	0.9 ± 0.1	0.8 ± 0.2	0.8 ± 0.1	0.0001**	0.0001**

Abbreviation: SD Standard deviation, eABG Estimated average blood glucose, SBP Systolic blood pressure, DBP Diastolic blood pressure, TG Triglycerides, HbA1c Glycated Haemoglobin, HDL-C High Density Lipid-Cholesterol, LDL-C Low Density Lipid-Cholesterol, VLDL-C Very Low Density Lipid-Cholesterol, M Male, F Female, C_F Control arm final, I_F intervention arm final
p-values; **p < 0.001–0.0001

ISSN: 1472-6963